0000899140-25-000986.txt : 20250814
0000899140-25-000986.hdr.sgml : 20250814
20250814161535
ACCESSION NUMBER: 0000899140-25-000986
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20250630
FILED AS OF DATE: 20250814
DATE AS OF CHANGE: 20250814
EFFECTIVENESS DATE: 20250814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
ORGANIZATION NAME:
EIN: 900924432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15935
FILM NUMBER: 251219338
BUSINESS ADDRESS:
STREET 1: 500 WEST PUTNAM AVENUE, SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 500 WEST PUTNAM AVENUE, SUITE 400
CITY: GREENWICH
STATE: CT
ZIP: 06830
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001577524
XXXXXXXX
06-30-2025
06-30-2025
false
Sarissa Capital Management LP
500 WEST PUTNAM AVENUE, SUITE 400
GREENWICH
CT
06830
13F HOLDINGS REPORT
028-15935
N
Alexander J. Denner, Ph.D.
Chief Investment Officer
203-302-2330
/s/ Alexander J. Denner
Greenwich
CT
08-14-2025
0
7
154389546
INFORMATION TABLE
2
informationtable.xml
AMARIN CORP PLC
SPONSORED ADR
023111404
20153788
1242527
SH
SOLE
1242527
0
0
CYTOKINETICS INC
COM NEW
23282W605
19439315
588357
SH
SOLE
588357
0
0
INNOVIVA INC
COM
45781M101
56573882
2816022
SH
SOLE
2816022
0
0
IRONWOOD PHARMACEUTICALS INC
COM CL A
46333X108
11417419
15919435
SH
SOLE
15919435
0
0
LANTHEUS HLDGS INC
COM
516544103
7879107
96251
SH
SOLE
96251
0
0
NEUROCRINE BIOSCIENCES INC
COM
64125C109
38103049
303151
SH
SOLE
303151
0
0
VOR BIOPHARMA INC
COM
929033108
822986
508016
SH
SOLE
508016
0
0